Related Experiment Video

Updated: Aug 23, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

[Control and prevention of cardiovascular disease around the world]

Ignacio Balaguer Vintró

    Revista Espanola De Cardiologia
    |July 1, 2004
    PubMed

    Insights

    Cardiovascular disease (CVD) prevention requires integrated strategies in developing nations due to limited resources. Combining CVD prevention with other chronic disease measures is crucial for global health equity.

    Area of Science:

    • Global epidemiology of cardiovascular diseases (CVD).
    • Analysis of CVD risk factors using Omran's epidemiological transition model.
    • Public health resource allocation in developing countries.

    Background:

    • Presents the global landscape of cardiovascular disease (CVD) prevalence and trends.
    • Examines major CVD risk factors through the lens of Omran's epidemiological transition model.
    • Highlights resource limitations and suboptimal utilization in developing nations based on World Heart Federation data.

    Discussion:

    • Identifies a scarcity of CVD management guidelines in many countries.
    • Notes a disconnect between guideline availability and the significance of specific diseases or risk factors.
    • Emphasizes the need for integrated preventive strategies for CVD and other chronic diseases due to economic constraints in populous developing countries.

    Key Insights:

    • Limited human and technical resources hinder effective CVD management in developing countries.
    • Few nations possess comprehensive guidelines for managing CVD and its risk factors.
    • Integrated prevention programs are essential for addressing CVD and other chronic diseases cost-effectively.

    Outlook:

    • Recommends enhancing information dissemination facilities.
    • Advocates for fostering research environments in developing countries.
    • Proposes integrating WHO chronic disease control innovations into primary care and supporting World Heart Federation initiatives.

    Related Concept Videos

    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    Regulation of the Cardiovascular System01:27

    Regulation of the Cardiovascular System

    The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
    The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
    The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
    Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

    Cardiovascular Drugs: Classification based on Therapeutic Indications

    Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    Hypertension and Regulation of Blood Pressure01:18

    Hypertension and Regulation of Blood Pressure

    Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...